Jump to navigation
OHE Consulting produces a report critiquing a paper by Hill et al. (2018) on estimated costs of production for the WHO Essential Medicines List.
OHE Consulting has produced a report summarising the literature on indication-based pricing and how it has been applied in the U.S. and 5 European countries.
A new OHE report discusses NICE’s introduction of a cost-effectiveness threshold to appraise ultra-orphan drugs.
OHE Consulting publishes a report on the barriers to the uptake of minimal access surgery in the NHS and private sector.
A recent paper examines EQ-5D-5L outcomes in patients with overactive bladder and compares them to results on the OAB-5D, a condition-specific measure.
This report explores the consequences of the exit of the United Kingdom (UK) from the European Union (EU) on public health in the UK and in the EU.
OHE’s Deputy Director Paula Lorgelly is standing as a candidate for the International Health Economics Association Board of Directors
For Open Access Week 2017, the Office of Health Economics highlights its research publication archive dating back to 1962
OHE publishes a report assessing the capacity in South Korea for the collection and use of real-world data in health care.
The presentations delivered by OHE at the HTAi Annual Meeting, June 2017, are available in this post.
The 2020 OHE Annual Lecture explores the question: how should the world pay for a COVID-19 vaccine?
Victor R. Fuchs Award for 2020 goes to Patricia Danzon
OHE authors develop a supply and demand model of pharmaceutical markets to set cost-effectiveness thresholds to maximise and distribute social welfare